Related Experiment Videos
[Active and passive immunization against hepatitis B virus infection]
Mikrobiyoloji Bulteni
|January 1, 1982
Summary
Hepatitis B immunoglobulin and vaccines offer effective prevention against hepatitis B virus infection. Vaccines, derived from HBsAg, achieve a 95% antibody response, crucial for high-risk groups.
Area of Science:
- Immunology
- Virology
- Vaccinology
Context:
- Hepatitis B virus (HBV) infection poses a significant public health challenge.
- Prevention and prophylaxis strategies are essential to control HBV transmission.
Purpose:
- To review the efficacy of immune serum globulin and hepatitis B immunoglobulin for HBV prevention.
- To discuss the role and effectiveness of hepatitis B virus vaccines.
Summary:
- Immune serum globulin and hepatitis B immunoglobulin are effective for pre- and postexposure prophylaxis against HBV, with hepatitis B immunoglobulin showing greater efficacy.
- Hepatitis B virus vaccines, developed from hepatitis B surface antigen (HBsAg) and its polypeptides, demonstrate high efficacy, achieving approximately 95% antibody response.
- Vaccination is recommended for high-risk populations including healthcare workers, surgeons, dentists, men who have sex with men, and infants in endemic areas.
Impact:
- Provides guidance on optimal use of immunoglobulins and vaccines for hepatitis B prevention.
- Highlights the importance of HBsAg vaccination for specific at-risk populations.
- Contributes to strategies for reducing the global burden of hepatitis B infection.